CIK 0001593899 · Non-accelerated filer<br>Smaller reporting company
Atea Pharmaceuticals, Inc.
Sign in to watch- Ticker
- AVIR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- MA
- Entity type
- operating
- EIN
- 460574869
- Phone
- (857) 284-8891
- Business address
- 225 FRANKLIN STREET, SUITE 2100, BOSTON, MA, 02110
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-31 | Vavricka John Chief Commercial Officer | Option exercise · Restricted Stock Units | −33,333 | 0 | ||
| 2026-01-31 | Vavricka John Chief Commercial Officer | Option exercise · Restricted Stock Units | −8,750 | 0 | ||
| 2026-01-31 | Vavricka John Chief Commercial Officer | Grant or award · Stock Option (Right to Buy) | +119,520 | 119,520 | ||
| 2026-01-31 | Hammond Janet MJ Chief Development Officer | Option exercise | +58,050 | 141,801 | ||
| 2026-01-31 | Hammond Janet MJ Chief Development Officer | Shares withheld for taxes | −14,136 | $4.24 | $60K | 127,665 |
| 2026-01-31 | Hammond Janet MJ Chief Development Officer | Option exercise · Restricted Stock Units | −46,800 | 0 | ||
| 2026-01-31 | Hammond Janet MJ Chief Development Officer | Option exercise · Restricted Stock Units | −11,250 | 0 | ||
| 2026-01-31 | Hammond Janet MJ Chief Development Officer | Grant or award · Stock Option (Right to Buy) | +177,000 | 177,000 | ||
| 2026-01-31 | Corcoran Andrea See Remarks | Option exercise | +54,866 | 779,680 | ||
| 2026-01-31 | Corcoran Andrea See Remarks | Shares withheld for taxes | −16,104 | $4.24 | $68K | 763,576 |
| 2026-01-31 | Corcoran Andrea See Remarks | Option exercise · Restricted Stock Units | −44,366 | 0 | ||
| 2026-01-31 | Corcoran Andrea See Remarks | Option exercise · Restricted Stock Units | −10,500 | 0 | ||
| 2026-01-31 | Corcoran Andrea See Remarks | Grant or award · Stock Option (Right to Buy) | +180,000 | 180,000 | ||
| 2026-01-31 | Sommadossi Jean-Pierre President, CEO, and Chairman | Option exercise | +272,983 | 573,923 | ||
| 2026-01-31 | Sommadossi Jean-Pierre President, CEO, and Chairman | Shares withheld for taxes | −106,093 | $4.24 | $450K | 467,830 |
| 2026-01-31 | Sommadossi Jean-Pierre President, CEO, and Chairman | Option exercise · Restricted Stock Units | −173,466 | 0 | ||
| 2026-01-31 | Sommadossi Jean-Pierre President, CEO, and Chairman | Option exercise · Restricted Stock Units | −99,517 | 0 | ||
| 2026-01-31 | Foster Wayne EVP, Chief Accounting Officer | Option exercise | +41,333 | 91,461 | ||
| 2026-01-31 | Foster Wayne EVP, Chief Accounting Officer | Shares withheld for taxes | −12,132 | $4.24 | $51K | 79,329 |
| 2026-01-31 | Foster Wayne EVP, Chief Accounting Officer | Option exercise · Restricted Stock Units | −33,333 | 0 |
Page 3 of 14 · 280 trades